(19)
(11) EP 3 452 046 A1

(12)

(43) Date of publication:
13.03.2019 Bulletin 2019/11

(21) Application number: 17792603.7

(22) Date of filing: 01.05.2017
(51) International Patent Classification (IPC): 
A61K 31/56(2006.01)
A61K 31/573(2006.01)
 A61K 31/352(2006.01)
(86) International application number:
PCT/IL2017/050483
(87) International publication number:
WO 2017/191630 (09.11.2017 Gazette 2017/45)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
MA MD

(30) Priority: 02.05.2016 US 201615143694

(71) Applicant: Stero Biotechs Ltd.
5250606 Ramat Gan (IL)

(72) Inventors:
  • YESHURUN, Moshe
    4481400 Elqana (IL)
  • SAGIV, Sari Prutchi
    3885700 Kibbutz HaMaapil (IL)

(74) Representative: Boult Wade Tennant LLP 
Verulam Gardens 70 Gray's Inn Road
London WC1X 8BT
London WC1X 8BT (GB)

   


(54) CANNABIDIOL FOR REDUCING A STEROID DOSE AND TREATING INFLAMMATORY AND AUTOIMMUNE DISEASES